Why Does Cancer Spread to the Lungs So Often?
By Dennis Thompson HealthDay Reporter
FRIDAY, Jan. 3, 2025 -- The lungs are a tempting place for cancer cells -- so much so that more than half of people with advanced cancer elsewhere in their bodies wind up with lung tumors.
Researchers now think they know why.
Elevated levels of an amino acid called aspartate appear to allow cancer cells to grow more easily inside the lungs, researchers reported in a study published Jan. 1 in the journal Nature.
“We found high levels of aspartate in the lungs of mice and patients with breast cancer compared to mice and patients without cancer, which suggests that aspartate may be important for lung metastasis,” lead researcher Ginevra Doglioni, a doctoral student with the Flemish Institute for Biotechnology’s Center for Cancer Biology in Belgium, said in a news release from the college.
For the study, researchers examined the genetic activity of tumor cells taken from aggressive lung cancers.
They found that aspartate -- an amino acid used to make proteins in the body -- appeared to trigger gene activity that results in higher cancer aggressiveness and more risk for lung tumors.
Aspartate appears in very low levels in the bloodstream, but it showed up in very high concentrations in the lungs of mice with advanced breast cancer, results show.
Researchers noted a similar process when examining human lung tumor samples, results show.
Essentially, aspartate activates a surface protein on cancer cells that results in a gene signaling cascade. This cascade of activity enhances the ability of cancer cells to alter their environment and make it more suitable for aggressive growth.
These findings could help doctors keep the lungs cancer-free, even in advanced cases where cancer is spreading to other parts of the body, researchers explained.
The research team also noted that drugs are already on the market that target the processes which appear to make lungs more cancer-prone.
“There are drugs available to target the mechanism we identified and thus with further research a translation toward a clinical setting might be possible,” senior researcher Sarah-Maria Fendt, a principal investigator with the Flemish Institute for Biotechnology’s Center for Cancer Biology, said in a news release.
Sources
- Flemish Institute for Biotechnology, news release, Jan. 2, 2025
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Mean Age of Moms at First Birth Increased From 2016 to 2023
MONDAY, June 16, 2025 -- From 2016 to 2023, there was an increase in the mean age of mothers at first birth and at higher-order births, according to the June 13 National Vital...
New COVID Variant, NB.1.8.1, May Now Make Up 1 in 3 U.S. Cases
MONDAY, June 16, 2025 — A new COVID-19 variant that led to a spike in hospital cases across parts of Asia may now account for more than one-third of all COVID cases in the...
ADHD Stimulants Can Be Safely Prescribed Via Telehealth, Study Argues
MONDAY, June 16, 2025 — People with ADHD might be prescribed their meds remotely without increasing their risk of addiction, a new study says. Experts have worried that...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.